Table 1.
Characteristics | Cases (n = 795) | Controls (n = 795) | p-Value | ||
---|---|---|---|---|---|
Age, mean (SD) | 50.5 | (9.5) | 50.3 | (9.4) | 0.730 a |
Educational level, n (%) | |||||
No formal school education/First grade | 173 | (22) | 132 | (17) | 0.001 a |
Second grade/Vocational training | 424 | (53) | 406 | (51) | |
University graduate | 198 | (25) | 257 | (32) | |
Age at menarche, mean (SD) | 12.6 | (1.5) | 12.5 | (1.5) | 0.159 b |
Age at first birth, mean (SD) | 26.5 | (4.4) | 26.2 | (4.4) | 0.129 b |
Number of children, n (%) | |||||
None | 172 | (22) | 178 | (22) | 0.970 a |
1–2 | 479 | (60) | 479 | (60) | |
3–4 | 133 | (17) | 128 | (16) | |
>4 | 11 | (1) | 10 | (1) | |
Menopausal status, n (%) | |||||
Premenopausal | 451 | (57) | 412 | (52) | 0.050 a |
Postmenopausal | 344 | (43) | 383 | (48) | |
Body mass index, Kg/m2, mean (SD) | |||||
Premenopausal | 24.5 | (4.3) | 24.8 | (4.5) | 0.146 b |
Postmenopausal | 27.1 | (4.9) | 26.3 | (4.1) | 0.009 b |
Waist circumference (cm) | 88.1 | (14.2) | 87.2 | (12.8) | 0.146 b |
Hormone replacement therapy use, n (%) | |||||
Never | 702 | (88) | 712 | (90) | 0.386 b |
Ever | 93 | (12) | 83 | (10) | |
Previous benign breast problems, n (%) | |||||
No | 620 | (78) | 651 | (82) | 0.052 a |
Yes | 175 | (22) | 144 | (18) | |
Family history of breast cancer, n (%) | |||||
None | 597 | (75) | 639 | (80) | 0.033 a |
Second degree | 101 | (13) | 85 | (11) | |
First degree | 97 | (12) | 71 | (9) | |
Self-assessed physical activity last year, n (%) | |||||
Sedentary/slightly active | 297 | (37) | 266 | (33) | 0.332 b |
Moderately active | 281 | (35) | 313 | (39) | |
Active/very active | 217 | (27) | 217 | (27) | |
Alcohol consumption (g/day), n (%) | |||||
No | 190 | (24) | 184 | (23) | 0.537 b |
<10 | 440 | (55) | 469 | (59) | |
≥10 | 164 | (21) | 142 | (18) | |
Smoking, n (%) | |||||
Never smoker | 343 | (43) | 332 | (42) | 0.367 b |
Former smoker ≥ 6 months ago | 208 | (26) | 203 | (26) | |
Smoker or former smoker < 6 months | 244 | (31) | 260 | (33) | |
Caloric intake (Kcal/day), mean (SD) | 1991.1 | (623.4) | 1903.8 | (659.9) | 0.005 b |
Tumor subtype c, n (%) | |||||
HR+ | 532 | (67) | |||
HER2+ | 162 | (20) | |||
TN | 99 | (12) |
Abbreviations: HR+ = hormone receptor positive tumors (ER+ and/or PR+, with HER2-); HER2+ = human epidermal growth factor receptor 2 positive tumors; TN = triple negative tumors. a p-value resulting from Pearson Chi-Square test (completed variables). b p-value resulting from conditional logistic regression models (imputed variables). c Two breast cancer cases could not be classified.